HealthSingle-source
2.1
Colombia restores supply of epilepsy drug Urbadan after registration change
El EspectadorLO·CO·1 day ago
Colombia's health regulator Invima has issued a public alert about suspected counterfeit products in the Arrurrú children's cosmetic line. The warning is based on regulatory surveillance, but the extent of distribution and health risks remain unconfirmed. This matters as counterfeit children's products could pose safety hazards, prompting consumer caution and potential market disruption for the brand.